$ABP - The Hidden GEM Nobodyโs Watching ๐
This tiny biotech dropped from $10 to just $0.15 after IPO โ no reverse split, no dilution history โ and yet the market is asleep.
Hereโs the kicker:
๐ฅ Both lead programs are FULLY FUNDED ๐ฅ
๐น ABPโ102: $1.75B funding from Celltrion
๐น ABPโ201: $30M equity + $540M milestone deal from Abpro Bio
This company has zero debt, a clean cap table, and insiders just loaded up at market.
They hold global rights for major cancer and eye disease therapies, with multi-billion-dollar upside and milestone triggers ahead. And right now โ itโs trading at pennies.
This is not just undervalued. Itโs a once-in-a-lifetime biotech setup.
๐ 10x? Maybe.
๐ One of the biggest sleepers youโll ever find.
๐ From $10 to $0.15
๐ Next stop? Donโt say I didnโt tell you.
GLTA and of course NFA ๐ค๐ผ
$ABP
โ$17.00 to $36.00 coming let me explain
What OCGN did in 2021 if anyone remember!! From 0.2$ to 10$ !! The company is a cancer treatment developer who got listed recently at 10$ a share and dropped all the way to 0.15 cents, now what makes it a one time life opportunity is that itโs trading around 10 million market cap while itโs fully funded by the Celltrion company which has a market cap of 28 billion usd!! No risk of diluting!! Owners been buying recently!! Has an access to a billion in funding while setting at a 10 m market cap!!โ.
The $PINO chart is primed to keep running. Itโs over tripled market cap from 1M to 3.6M in less than a few weeks.
Get in while itโs still early my fellow degens! This definitely has $PONKE vibes written all over it. ๐ฆ @pinothedino